NIAGEN BIOSCIENCE, INC. Proceeds from Notes Payable
NIAGEN BIOSCIENCE, INC. (NAGE) reported Proceeds from Notes Payable of $0 for the 9-month period ending 2016-10-01, per its 10-Q filed 2016-11-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2016-11-10
- NIAGEN BIOSCIENCE, INC. proceeds from notes payable for the quarter ending 2015-10-03 was $0.00.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month |
|---|---|---|---|
| 2016-10-01 | $0.00 10-Q · filed 2016-11-10 | ||
| 2015-10-03 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $2.50M 10-Q · filed 2016-11-10 | |
| 2015-07-04 | $2.50M 10-Q · filed 2016-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |